Search

everythinglearnresearchcommunity

for

Search:↓

Aromatase inhibitors cause male pattern hair loss in women.

Androgen-producing ovarian tumors can cause male-pattern hair loss in women.

Trichoscopy is reliable for diagnosing different types of frontal non-scarring hair loss.

A woman's hair loss was linked to a rare hormone-secreting ovarian tumor, treated with surgery and hair loss medication.

Hair diameter difference, brown skin discoloration around hair follicles, and missing hair in certain areas are key signs of androgenetic alopecia (commonly known as hair loss) when viewed under a dermoscope.

Finasteride may help postmenopausal women with hair loss but is not effective for all and should be used cautiously in premenopausal women.

Alopecia areata can regrow hair in a pattern similar to androgenetic alopecia.

Serenoa repens extract in topical products improves hair growth and appearance in male pattern baldness with mild side-effects.

Female pattern hair loss may indicate metabolic issues and increased cardiovascular risk.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

Trichoscopy is better than trichogram for diagnosing female hair loss.

Trichoscopy can diagnose female hair loss with high accuracy by looking for specific patterns in hair and scalp appearance.

Trichoscopy is a useful non-invasive method to diagnose female hair loss with high accuracy.

Dermoscopy is useful for diagnosing different types of hair loss.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

Men with androgenetic alopecia may have higher triglycerides, suggesting a link to lipid metabolism.

Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.

The document concludes that hair loss in women can be treated with topical treatments or hormone therapy depending on the cause.

No significant link was found between the studied genes and female hair loss in the Polish population.

Platelet Rich Plasma (PRP) therapy can improve hair thinning in male pattern baldness patients, but more research is needed to confirm its effectiveness.

Scalp dermatoscopy helps diagnose and monitor hair loss severity.

Trichoscopy is a key method for dermatologists to quickly and effectively diagnose hair and scalp conditions.

Hair shedding increases at the end of summer due to seasonal changes.

In 2017, Spanish dermatologists most often prescribed minoxidil and finasteride for male hair loss, and minoxidil and oral contraceptives for premenopausal female hair loss.

Dermatologists recommend oral dutasteride for male hair loss, low-dose oral minoxidil for female hair loss, and a multidisciplinary approach for young patients, with caution during pregnancy.

Hair thickness differences help diagnose hair loss severity.

Longer CAG repeats in gene linked to more severe hair loss in females.

Topical cetirizine 1% promotes hair growth in male androgenetic alopecia patients.

Minoxidil effectively treats patterned hair loss in both males and females.